| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Supernus Pharmaceuticals, Inc. (SUPN) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. SUPN is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 119.6K | $5.32M | - | |
| Dir | 61.3K | $2.73M | - | |
| Dir | 38.2K | $1.70M | - | |
| VP | 15.5K | $689.3K | - | |
| VP | 14.5K | $645.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 22, 2025 | Dec Timothy C | Senior Vice-president &CFO | Sell | 11,780 | $44.49 | $524,092.20 | -90.4% | -0.2% | - | |
| Aug 22, 2025 | Khattar Jack A.64 | President, CEO | Sale+OE | 1,500 | $45.00 | $67,500.00 | -0.1% | -0.2% | - | |
| Aug 14, 2025 | Sensenig Bethany | Director | Sell | 5,369 | $42.25 | $226,840.25 | -100% | +5.8% | - | |
| Aug 14, 2025 | Hudson Frederick M. | Director | Sell | 7,457 | $42.26 | $315,132.82 | -13.9% | +5.8% | - | |
| Aug 6, 2025 | Khattar Jack A.64 | President, CEO | Sale+OE | 140,000 | $42.02 | $5,883,360.00 | -4.3% | +34.3% | - | |
| Feb 21, 2025 | Rubin Jonathan | SVP, Chief Medical Officer | Sale+OE | 927 | $39.15 | $36,292.05 | -10.6% | -3.1% | +53.9% | |
| Feb 4, 2025 | Bhatt Padmanabh P.69 | Sr. VP Of Ip, CSO | Sale+OE | 9,477 | $39.70 | $376,236.90 | -48.3% | -19.0% | +22.7% | |
| Jan 28, 2025 | Bhatt Padmanabh P.69 | Sr. VP Of Ip, CSO | Sale+OE | 3,273 | $39.62 | $129,676.26 | -13.9% | -17.6% | +25.0% | |
| Dec 3, 2024 | Bhatt Padmanabh P.69 | Sr. VP Of Ip, CSO | Sale+OE | 21,495 | $36.68 | $788,436.60 | -52.6% | -14.3% | +20.9% | |
| Nov 11, 2024 | Newhall Charles W III | Director | Sale+OE | 10,700 | $36.24 | $387,768.00 | -7.6% | +3.6% | +25.9% |